Grail merging with Cirina

Circulating tumor DNA (ctDNA) testing company Grail Inc. (Menlo Park, Calif.) said it will merge with cancer diagnostics developer Cirina Ltd. (Hong Kong, China).

Grail spokesperson Charlotte Arnold told BioCentury that Cirina will become a subsidiary of Grail with a focus on the Southeast Asia region. In Hong Kong, Cirina will continue to operate under its existing name, while Cirina's U.S. workforce will join Grail. Cirina has an ongoing research collaboration with the Chinese University of Hong Kong...